Scientists Create New Leukemia Treatment From Survivors' Cells

Researchers at Memorial Sloan Kettering developed a groundbreaking CAR T cell therapy that targets leukemia while sparing healthy blood cells.

The innovation came from studying patients whose cancer went into long-term remission.